Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece

Multiple Sclerosis Journal - Tập 16 Số 9 - Trang 1091-1101 - 2010
Georgia Deretzi1, Jannis Kountouras2, Evangelos Koutlas1, Christos Zavos2, Stergios A. Pοlyzos2, Jobst Rudolf1, Nikolaos Grigoriadis3, Emmanuel Gavalas2, Marina Boziki2, Iakovos Tsiptsios1
1Department of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital, Thessaloniki, Greece,
2Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
3B’ Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Tóm tắt

Objective: The objective of this study was to evaluate for up to 7 years the prevalence of autoimmune disorders among naïve (untreated) multiple sclerosis family members compared with a contemporary general control population in Northern Greece, in a prospective case-control study, and to examine the possible relationship between immunomodulatory treatment and the appearance of additional autoimmune disorders. Methods: The patients and controls enrolled comprised 1383 patients with definite MS and 4392 relatives in their families and a total of 452 controls families with 1652 members. Results: At baseline, 891 multiple sclerosis families with 3112 members (73 multiplex multiple sclerosis families with 292 members and 818 simplex families with 2820 members) and 355 control families with 1580 members were examined regarding whether they had any of 12 autoimmune diseases. The baseline affected multiplex plus simplex multiple sclerosis families, the family members and the coexistent additional autoimmune disorders were higher compared with controls. There was an increase in longitudinally affected multiple sclerosis families, multiple sclerosis family members and coexistent additional autoimmune disorders compared with respective findings at the baseline observation. Comparison analysis between two time point observations (after a mean 7.1 ± 2.2 years) for each autoimmune disorder in overall multiple sclerosis family members revealed increased rates for longitudinal autoimmune Hashimoto’s thyroiditis, Graves’ disease, insulin-dependent diabetes mellitus, psoriasis and vitiligo ( p = 0.02, p = 0.006, p = 0.0004, p = 0.05, and p = 0.05, respectively). Some 145 newly developed, longitudinally definite autoimmune cases were recognized in multiplex plus simplex multiple sclerosis families; 116 (80%) of these disorders were observed in patients with multiple sclerosis treated with immunomodulatory medications, and 68 of these 116 (58.6%) cases exhibited baseline positive autoreactive antibodies. Binary logistic regression analysis revealed that immunotherapy predisposes to autoimmunity (odds ratio 2.8, p < 0.001) independently of the presence of baseline autoantibodies and patients’ gender. Conclusions: There is a longitudinally increased frequency of additional autoimmune disorders among multiple sclerosis family members, probably related to immunomodulatory therapy.

Từ khóa


Tài liệu tham khảo

10.1212/WNL.0b013e3181c97c8f

10.1038/ni1507

10.1016/j.jns.2009.09.005

10.1093/brain/awh152

10.1097/WCO.0b013e3282fee94a

10.1002/ana.21640

10.1001/archneur.63.7.1001

Sloka JS, 2005, J Autoimmune Dis, 9, 2

10.1034/j.1600-0404.2003.00158.x

10.1002/ibd.20406

10.1016/S1474-4422(06)70552-X

10.1054/jocn.2000.0693

10.1034/j.1600-0404.2000.101001036.x

10.1093/brain/123.6.1102

10.1177/1352458508088936

Laufer TM, 2009, J Clin Invest, 119, 2852, 10.1172/JCI40986

10.1002/ana.1032

10.1093/aje/kwn408

10.1016/j.jaut.2009.09.008

10.1002/ana.21911

10.1016/j.jaut.2009.03.007

10.1016/j.jneuroim.2007.06.007

10.1016/j.mehy.2009.04.021

10.1517/14740330903066726

10.1016/j.jneuroim.2007.04.008

10.2174/138161210791164144

10.1089/thy.2008.0290

Durelli L., 2001, J Clin Endocrinol Metab, 86, 3525

10.1212/01.WNL.0000154522.86947.86

10.1016/S0140-6736(99)02429-0

10.1056/NEJMoa0802670

10.1111/j.1365-2133.2008.09005.x

10.1016/j.cyto.2008.11.002

10.1111/j.1468-1331.2009.02563.x

10.3748/wjg.v13.i26.3638

10.1159/000143156

Thông tin
Thông tin xuất bản

Multiple Sclerosis Journal

Tập 16 Số 9

1091-1101

Thông tin tác giả